Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 227

1.

Medication utilization and annual health care costs in patients with type 2 diabetes mellitus before and after bariatric surgery.

Makary MA, Clark JM, Shore AD, Magnuson TH, Richards T, Bass EB, Dominici F, Weiner JP, Wu AW, Segal JB.

Arch Surg. 2010 Aug;145(8):726-31. doi: 10.1001/archsurg.2010.150. Erratum in: Arch Surg. 2011 Jun;146(6):659. Clarke, Jeanne M [corrected to Clark, Jeanne M].

PMID:
20713923
2.

Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study.

Balkrishnan R, Rajagopalan R, Camacho FT, Huston SA, Murray FT, Anderson RT.

Clin Ther. 2003 Nov;25(11):2958-71.

PMID:
14693318
3.
4.

Health care costs associated with escalation of drug treatment in type 2 diabetes mellitus.

Brown JB, Nichols GA, Glauber HS, Bakst AW, Schaeffer M, Kelleher CC.

Am J Health Syst Pharm. 2001 Jan 15;58(2):151-7.

PMID:
11202539
5.

Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in Medicaid-enrolled patients with type 2 diabetes mellitus.

Balkrishnan R, Arondekar BV, Camacho FT, Shenolikar RA, Horblyuk R, Anderson RT.

Clin Ther. 2007 Jun;29(6 Pt 1):1306-15.

PMID:
18036392
6.

A comparison of insulin use, glycemic control, and health care costs with insulin detemir and insulin glargine in insulin-naive patients with type 2 diabetes.

Borah BJ, Darkow T, Bouchard J, Aagren M, Forma F, Alemayehu B.

Clin Ther. 2009 Mar;31(3):623-31. doi: 10.1016/j.clinthera.2009.03.005.

PMID:
19393853
7.

Comparison of costs among patients with type 2 diabetes treated with exenatide or sitagliptin therapy.

Lage MJ, Fabunmi R, Boye KS, Misurski DA.

Adv Ther. 2009 Feb;26(2):217-29. doi: 10.1007/s12325-009-0002-0. Epub 2009 Feb 14.

PMID:
19219409
8.

Direct medical costs for type 2 diabetes mellitus complications in the US commercial payer setting: a resource for economic research.

Pelletier EM, Smith PJ, Boye KS, Misurski DA, Tunis SL, Minshall ME.

Appl Health Econ Health Policy. 2008;6(2-3):103-12. doi: 10.2165/00148365-200806020-00003.

PMID:
19231904
9.
10.

A comparison of costs among patients with type 2 diabetes mellitus who initiated therapy with exenatide or insulin glargine.

Misurski D, Lage MJ, Fabunmi R, Boye KS.

Appl Health Econ Health Policy. 2009;7(4):245-54. doi: 10.2165/11318730-000000000-00000.

PMID:
19905038
11.

Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modeled lifetime analysis.

Keating CL, Dixon JB, Moodie ML, Peeters A, Bulfone L, Maglianno DJ, O'Brien PE.

Diabetes Care. 2009 Apr;32(4):567-74. doi: 10.2337/dc08-1749. Epub 2009 Jan 26.

12.

Short-term medication cost savings for treating hypertension and diabetes after gastric bypass.

Ghiassi S, Morton J, Bellatorre N, Eisenberg D.

Surg Obes Relat Dis. 2012 May-Jun;8(3):269-74. doi: 10.1016/j.soard.2011.05.009. Epub 2011 May 27.

PMID:
21723203
13.

Economics of type 2 diabetes prevention.

Kissimova-Skarbek K.

Przegl Lek. 2006;63 Suppl 4:9-11. Review. No abstract available.

PMID:
16967708
14.

Should future health-care costs be discounted? The case of diabetes in Australia.

Scuffham PA.

Intern Med J. 2006 Mar;36(3):148-9. No abstract available.

PMID:
16503948
15.

Estimating the direct cost of Type 2 diabetes in Greece: the effects of blood glucose regulation on patient cost.

Athanasakis K, Ollandezos M, Angeli A, Gregoriou A, Geitona M, Kyriopoulos J.

Diabet Med. 2010 Jun;27(6):679-84. doi: 10.1111/j.1464-5491.2010.03004.x.

PMID:
20546287
16.

Cost sharing, adherence, and health outcomes in patients with diabetes.

Gibson TB, Song X, Alemayehu B, Wang SS, Waddell JL, Bouchard JR, Forma F.

Am J Manag Care. 2010 Aug;16(8):589-600.

17.
18.

A study on the economic impact of bariatric surgery.

Cremieux PY, Buchwald H, Shikora SA, Ghosh A, Yang HE, Buessing M.

Am J Manag Care. 2008 Sep;14(9):589-96.

19.
20.

State of diabetes care in the United States.

Blonde L.

Am J Manag Care. 2007 Apr;13 Suppl 2:S36-40. Review.

Supplemental Content

Support Center